The studies on the cytotoxicity in vitro, cellular uptake, cell cycle arrest and apoptosis-inducing properties of ruthenium methylimidazole complex [Ru(MeIm)4(p-cpip)](2.)

Journal of Inorganic Biochemistry
Lanmei ChenJin-can Chen

Abstract

A new ruthenium methylimidazole complex [Ru(MeIm)4(p-cpip)](2+) (Ru1, p-cpip=2-(4-chlorophenyl)-1H-imidazo[4,5-f][1,10]phenanthroline, MeIm=1-methylimidazole) has been synthesized and characterized. The cellular uptake, in vitro cytotoxicities, cell cycle arrest and apoptosis-inducing mechanism of this Ru(II) complex have been extensively explored by Inductively Coupled Plasma Mass Spectrometry (ICP-MS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, flow cytometry, Comet assay, inverted fluorescence microscope as well as Western blotting experimental techniques. Notably, Ru1 displayed relatively high cytotoxic activity against lung cancer A549 cells and had high selectivity between tumor and normal cells in comparison with cisplatin. Further studies showed that Ru1 caused cell cycle arrest at G0/G1 phase and induced apoptosis via the mitochondrial pathway, which involved reactive oxygen species (ROS) accumulation, mitochondrial dysfunction and Bcl-2 and caspase correlative family member activation. For providing more information about the possible antitumor mechanism, the in vitro DNA binding studies have been also investigated by different spectrophotometric methods, thermal denaturation and viscosi...Continue Reading

References

Mar 5, 1999·Science·D C Wallace
Oct 18, 2000·Free Radical Biology & Medicine·E Cadenas, K J Davies
Aug 3, 2002·Nature Reviews. Cancer·Karen H Vousden, Xin Lu
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
May 1, 2004·Trends in Pharmacological Sciences·Lorne J HofsethCurtis C Harris
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeany M Rademaker-LakhaiJan H M Schellens
May 14, 2005·CA: a Cancer Journal for Clinicians·Irene M GhobrialAlex A Adjei
Jun 27, 2007·Journal of Pharmaceutical Sciences·Tomris Ozben
Nov 6, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hideki Mizutani
Nov 1, 2009·Metallomics : Integrated Biometal Science·Aviva LevinaPeter A Lay
Dec 14, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·Linlin LiWenjie Zheng
Mar 14, 2013·Metallomics : Integrated Biometal Science·Chen QianHui Chao

❮ Previous
Next ❯

Citations

Jul 6, 2016·Archives of Toxicology·M GleiW Schlörmann
Nov 4, 2016·International Journal of Molecular Sciences·Krishant M DeoJanice R Aldrich-Wright
Oct 13, 2017·European Journal of Immunology·Andrea CossarizzaJakob Zimmermann
Feb 7, 2019·Dalton Transactions : an International Journal of Inorganic Chemistry·Vivianne S Velozo-SáElisângela P Silveira-Lacerda

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis